Form 4: Agilon Health CTO Reports Tax-Related Share Withholding

Agilon Health Chief Technology Officer Girish Venkatachaliah reported the withholding of 426 shares to cover tax obligations related to restricted stock units.

Summary

• Girish Venkatachaliah, Chief Technology Officer of agilon health, inc., executed a net settlement of restricted stock units.
• A total of 96 shares were withheld on April 14, 2026, at a price of $22.68 per share.
• A total of 330 shares were withheld on April 15, 2026, at a price of $26.88 per share.
• These transactions were mandatory tax withholdings and do not represent open-market sales by the executive.
• Following these transactions, the reporting person maintains a beneficial ownership of 38,236 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine administrative action related to tax withholding rather than a discretionary market trade.

Positives

• The transaction reflects the vesting of equity compensation, which aligns the executive's interests with long-term shareholder value.

Negatives

• None; this is a routine administrative transaction related to tax compliance.

Risks

• None; this filing pertains to standard equity compensation tax withholding.

Future Outlook

Not applicable; this is a historical disclosure of an equity transaction.

Industry Context

StockSavvy.ai notes that net settlement transactions are standard practice for executives in the healthcare technology sector to manage tax liabilities upon the vesting of restricted stock units, carrying no signal regarding management's outlook on company performance.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices for equity-based compensation in the U.S. healthcare sector.
• The use of net settlement is consistent with industry norms for publicly traded companies to facilitate tax compliance for employees.

Stakeholder Impact

• No material impact on shareholders, employees, or creditors as this is a standard tax-related equity settlement.

Key Dates

Keywords

agilon health, AGL, insider transaction, Form 4, equity compensation, tax withholding